Mortality of Patients Undergoing Fracture of the Upper Extremity u Femur at the University Hospital of Amiens

Fractures of the upper femur (EFSF) represent a major public health problem in the elderly. Approximately 1.6 million patients are victims each year of an EFSF and this number is increasing as a result of the aging of the population.

In a recent Amiens retrospective study the mortality was estimated to be 22.5% at 1 year of the fracture. In surviving patients, the impact on loss of autonomy and degradation of quality of life is considerable.

The reduction of the incidence of post-operative complications includes the identification of risk factors.

No prospective study in Amiens has investigated the mortality and the study of the variables involved in the prognosis and long-term mortality of these patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Femur Fracture Femoral Fractures Fractures, Bone Leg Injuries Morality Wounds and Injuries

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Amiens Picardie

Amiens, Picardie, 80054, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All the patients operated from a fracture of traumatic origin of the ESF to the emergency block at the CHU of Amiens
Patients transferred to the CHU after being cared for in another structure will be included.
If a patient successively presents a fracture of each upper extremity of the femur outside of a surgical resumption, two inclusions will be realized

Exclusion criteria

Do not include non-traumatic fractures of the upper end of the femur (pathological fractures: cancer, for example)
Fractures of the upper end of the femur associated with polytrauma will not be included.

Treatment and study plan

Study of mortality at 6 months

Other

The objective is to provide strong arguments for establishing a dynamic of collective care for patients suffering from an EFSF

Primary outcomes

Mortality at 6 months of EFSF patients

Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire, Amiens

Other

Registry information

Acronym: FESF-Amiens

Important dates

Study start: 2016
Primary completion: 2017
Study completion: 2017
First posted: Apr 18, 2017
Registry last updated: Jul 20, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed